We used dual laser two-color flow cytometry to compare the expression of surface markers associated with activation and with differentiation in lung and peripheral blood T lymphocytes from normal subjects. T cell subsets, defined based on their reactivity with monoclonal antibodies (MAb) OKT3, OKT4, and OKT8, were analyzed for expression of activation antigens as detected by MAbs to the interleukin-2 receptor, the transferrin receptor, and HLA-DR determinants. Whereas circulating T lymphocytes expressed the three activation antigens at low levels, and the total of T4' and TS' cells always approximated the number of T3' cells, lung T lymphocytes of the T3', T4+, and T8+ populations expressed the activation antigens at variable levels in combinations not seen in circulating lymphocytes, and the sum of T4+ and TS' cells always exceeded the T3+ total. A proportion of T4+T8+ cells was detected in lung lymphocytes.
Introduction
Considerable interest in the role of T lymphocytes in the etiology and pathogenesis of some human lung diseases has prompted studies of phenotypic and functional characterization of these cells. Cells obtained from bronchoalveolar lavage (BAL)' have shed considerable light on disease processes (1) and have been shown to correspond with those in the lung parenchyma (2) . Comparison of T cells obtained from BAL to those circulating in peripheral blood of pulmonary sarcoidosis patients (3, 4) has revealed higher ratios of helper/inducersuppressor/cytotoxic (T4+/T8+) T cells in the lung. Hypersensitivity pneumonitis has been reported to be associated with lower (5) and comparable (6) T cell ratios in lung vs. blood, while pulmonary fibrosis has been found to have both normal (3) and low (4) ratios. 1 . Abbreviations used in this paper: AMF, alveolar macrophages; AMV, avian myeloblastosis virus; Av-TxR, avidin-Texas Red; BAL, bronchoalveolar lavage; FITC, fluorescein isothiocyanate; IL-2, interleukin-2; MAb, monoclonal antibody(ies); PBMC, peripheral blood mononuclear cells; TxR, Texas Red. However, these same studies have not always similarly identified BAL T cell markers in normal subjects. In fact, no systematic study of phenotypic markers of differentiation for BAL T cells in normal subjects exists, largely due to the low total cell yields and low lymphocyte percentages obtained. Total T cells in BAL in controls have often been quantitated and prepared using rosetting techniques (3) , and in one study (5) , using an OKT3 monoclonal antibody (MAb), which detects mature T cells. The nonoverlapping nature of the OKT4' and OKT8' subsets and the fact that they comprise the total OKT3' subset (4, 7) have never been demonstrated for other than circulating T cells; concurrent expression of T4 and T8 antigens is the rule in thymic T cell maturation (8) . Moreover, recent studies have shown that a large proportion of cells with natural killer activity that are not clearly T cells form sheep erythrocyte rosettes and bind OKT8 (9) , and that circulating monocytes may bind OKT4 (10). Thus, an attempt to characterize the surface phenotype of lung T cells in normal subjects becomes even more important for reference purposes.
Differences in T4+/T8' ratios in the lung vs. the peripheral blood of patients with immunologic lung diseases could, in part, reflect inherent differences of surface marker expression that exist between circulating and lung T cells in normal subjects.
Similar questions pertain to surface marker expression of BAL T cell activation in controls. We (11) and others (12) have noted in preliminary reports the presence of Ia and Tac antigens on BAL T cells in a few sarcoid patients and normal subjects. Another study assessed BAL cell activation in sarcoidosis and hypersensitivity pneumonitis by flow cytometry analysis of cell cycle stage, but did not include BAL data for normal controls or any surface marker data (13) .
To clarify these issues, we sought to characterize surface marker expression on lung T cells in normal nonsmoking controls. Using a two-color technique, we employed dual laser flow cytometry to determine coexpression of multiple differentiation, activation, and cell cycle stage parameters. We found that normal BAL T cells were mostly noncycling, but expressed activation surface markers on T3' cells as well as on T4' and T8+ subsets, and some cells coexpressed both T4+ and T8+ phenotypes.
Methods
Human subjects. Nonsmoking volunteers between the ages of 21 and 29 with normal chest fluoroscopy and no antecedent history of lung disease gave written informed consent to undergo BAL and venipuncture under a proposal approved by our institutional Human Studies Committee. The technique of BAL has been described in detail (1, 14) ; briefly, after venipuncture with aspiration of 30 ml of blood, volunteers received upper airway topical anesthesia with 2% lidocaine by aerosol, 0.6 ml atropine was injected subcutaneously, and the fiberoptic bronchoscope was passed to the right middle lobe under direct vision with more topical lidocaine anesthesia as required. Up to 400 ml of sterile physiologic saline solution was introduced, and fluid recovery varied from 55 to 70%. BAL cell yields and differential cell counts are shown in Table I .
Preparation oflung and blood cells. Fluid recovered from BAL was poured through 40-gauge steel gauze and cells were centrifuged in the cold. The pellet was washed three times in Hanks' balanced salt solution without Ca"2 or Mg'2, pH 7.20. An aliquot was removed for total and differential (by cytocentrifuge) cell counting and viability, determined by customary techniques (15) , and the remainder was layered upon Ficoll-Hypaque and centrifuged at room temperature for 40 min. The interface layer was washed three times in MAb buffer (Ca+2-and Mg+2-free phosphate-buffered saline (PBS) with 10-2 M EDTA, 0.1% sodium azide, and 2% bovine serum albumin, pH 7.2) and resuspended to a concentration of at least 2 X 10' cells/ml. FicollHypaque pellets contained erythrocytes, bronchial epithelial cells, and some lymphocytes, monocytes, occasional granulocytes, and alveolar macrophages (AMF) that stained with trypan blue. Washed interface cells consisted of lymphocytes and AMF.
Peripheral blood was diluted 1:2, layered onto Ficoll-Hypaque, and peripheral blood mononuclear cells (PBMC) were subsequently treated like BAL cells. All samples were handled uniformly and promptly to minimize selective loss of T cell markers associated with storage and temperature (16, 17) . Analysis of T cell subset distribution (described below) revealed no selective alterations as a function of filtering through steel gauze or layering onto Ficoll-Hypaque.
Monoclonal antibodies to surface markers. The following MAbs were used: OKT3, OKT4, OKT8 (Ortho Diagnostics, Raritan, NJ) for pan-T, helper/inducer, and suppressor/cytotoxic T cell antigens, respectively (7, 8, 18) ; anti-human DR (19, 20 Antibody conjugations. Anti-Tac, L5. 1, and S 1-37 were conjugated with biotin (e.g., Tac-B) by reaction of 1 ml of column-purified antibody (1 mg/ml) in 0.1 M NaHCO3 (pH 8.4) with 120 gl biotin succinimide ester (Bioseartch, San Natale, CA) (dissolved at 1 mg/ml in dimethyl sulfoxide) at room temperature for 4 h. DR-B was 
Results
Differentiation antigens. The proportion of T3' cells in peripheral blood of subjects studied (mean 68%; Fig. 2 ) equaled the sum (within 5%) of T4' and T8V cells; <2% of lymphocytes ever expressed both T4 and T8 antigens, consistent with prior reports (7, 8) . In contrast, lung T lymphocytes (Table II) showed a decreased proportion of T3' cells (mean 49%), and the sum of the T4' and T8+ cells always exceeded the T3+ total, although T4/T8 ratios were within the normal range (mean 1.9). Two-color immunofluorescence analysis of T4+ presence of Tac, DR, and L5. 1 antigens on mature circulating T (T3+) cells revealed only a small proportion of dual-labeled cells (Fig. 4) . Very variable percentages of lung lymphocytes displayed activation antigens (Table III) . While some subjects showed <7% Tac+ cells, subjects 3, 5, and 6 showed elevated Tac expression on T3+, T4+, and T8+ cells. Simultaneous expression of activation antigens was studied on lung lymphocytes of six subjects (Table IV) . Dual staining for Tac and DR revealed a proportion of T cells expressing both antigens (subject 5) . A maximum of 5% of lymphocytes coexpressed L5.1 and DR, although neither of these latter antigens are specific for T lymphocytes and may be identifying activated or proliferating B cells (22, 28, 29) .
Cell cycle analysis. In four subjects studied by two-color cell cycle analysis in which DNA-stained cells accounted for >80% of the lymphocyte population, nearly all cells were nonproliferating in Go/GI (Table V) . The majority of Tac+ and DR' cells were found in this population, although a few were found in cells with increased DNA staining identifying the latter as actively dividing cells. Again, not all DR' cells showed T differentiation antigens, and some may be dividing B cells.
Discussion
Cell surface marker phenotyping by the binding of immunologically-specific MAbs has proven a powerful tool in dissecting patterns of cell participation in physiologic and pathologic immune processes, and knowledge of the functional specificity and significance of surface antigens continues to expand.
The differentiation antigen T3, found on circulating lymphocytes, not only identifies the mature T cell but in association with clonotypic Ti antigen appears to be the T cell receptor complex for antigen. Modulation (loss) of T3 antigen from the cell surface inhibits antigen-specific proliferation and cytotoxic capabilities, and enhances response to IL-2. The T3-Ti antigen complex appears at a late stage in thymic T cell ontogeny, and confers immunocompetence, which develops further when thymic lymphocytes are exported (8, 30) .
In data obtained from studies of several patients with pulmonary sarcoidosis or hypersensitivity pneumonitis (4, 5, 11) , T3 expression in the BAL lymphocyte gate has been .75%, as compared with our finding in 10 normal subjects of a mean value of 49%. The diminished T3 molecule expression on BAL lymphocytes of these normal subjects might be explained by either or both of two mechanisms: (1) modulation as a result of antigenic stimulation in the normal lung; and (2) incomplete in situ pulmonary maturation of partially differentiated T cells.
Concurrent expression of T4 and T8 antigens is the rule in stage II maturing thymocytes, which later further differentiate in the thymus, segregating into reciprocal T4' and T8V subsets. The functional specificity of these subsets is now known to be complex and heterogeneous, with cytotoxic cells present in both subsets and the T4+ subset containing both suppressor inducer and immunoglobulin-production helper functions (8) .
If the T4+T8+ cells we identified are mature and multifunctional, this implies more in vivo tissue diversity in the T cell repertoire than previously suspected from numerous studies of peripheral blood. Alternatively, these cells may be comparable 3  5  50  41  28  37  43  31  26  24  42  32  22  32  6  17  5  14  8  20  7  12  4  35  7   16   14  7  3  3  3  2  10  5  7  3  2  2  2  2  8  2  2  2  2  27  14  17  11  3  1   3  3  9  3  3  0  2  17  12  ND  8  5  4  2  6  10  6  6  6  6  10  4  5  6  14  12  13  10 * See Table 1I legend for explanation of data. (22, 28, 29) . On T cells, transient expression of the transferrin receptor appears to require prior IL-2 receptor expression and IL-2 binding (37). In our study, L5.1+T3+ cells never exceeded 5% of total peripheral blood lymphocytes (mean 2%), whereas the proportion of L5.1+ lung lymphocytes was variable never exceeding 32% of total lymphocytes of a single T lineage marker. Total binding of L5. 1 exceeded the sum of T3+, T4+, and T8+ cells in some cases, suggesting binding of the antibody to some lung lymphocytes without these T lineage markers.
Two-color studies of activation antigen expression as a function of cell cycle revealed nearly all lymphocytes to be in GO/GI in these normal subjects, and in one subject, Tac was expressed both in GO/GI and in dividing cells, as previously shown (38) . However, in contrast to that report, indicating DR only as a "late" antigen on in vitro proliferating T cells, we detected DR antigen on GO/GI as well as proliferating cells in subjects 7, 8, and 9. Although some of the (Go/GI)DR+ cells may have been B lymphocytes, the high numbers of DR' cells of T lineage (Table III) The pathophysiology and extent of T lymphocyte participation in human immunologic lung diseases remain to be clarified. Our study can serve to provide base-line data for the unexpected range of expression of surface markers of lung T cell differentiation and activation in controls. The data also show a preponderance of small lymphocytes in GO/GI with "proliferation" antigens (Tac, L5. 1) and DR antigen on T4+ and T8+ cells, in addition to demonstrating the presence of T4+T8+ and T3-cells. Their presence in normal controls is presumably physiologic, in response to inhaled and circulating antigens, and is an aid in determining the cellular repertoire available to the in vivo immune response.
